Effect of Aspergillus versicolor Fungus Extract on Some Bacterial Species
Keywords:
Aspergillus versicolor, Pseudomonas aeruginosa , Helicobacter pyloriAbstract
Fungus Aspergillus versicolor is a subject of extensive study in biomicrobiology and pharmaceutical science owing to its ability to generate an array of biologically active secondary metabolites. Introducing this fungus into different strains of bacteria, it is known that the effect is mainly on its inhibition and antibacterial activity, as in its extracts present substances with anti-pathogenic microorganisms growth. Aspergillus versicolor is a filamentous fungus that produces a variety of secondary metabolites with potential inhibitory effects on Pseudomonas aeruginosa bacteria. Research indicates that certain compounds derived from A. versicolor show antibacterial activity against P. aeruginosa, including the inhibition of cell division and DNA-based metabolic interference. Other research suggests a multifaceted relationship between Aspergillus versicolor fungus and Helicobacter pylori bacteria, which includes both inhibitory effects from secondary metabolites and potential synergistic, carcinogenic, or concurrent associations.
References
- Géry A, Séguin V, Eldin de Pécoulas P, Bonhomme J, Garon D. Aspergilli series Versicolores: importance of species identification in the clinical setting. Critical Reviews in Microbiology. 2023 Jul 4;49(4):485-98.
- Abdel-Azeem AM, Abdel-Azeem MA, Abdul-Hadi SY, Darwish AG. Aspergillus: Biodiversity, ecological significances, and industrial applications. InRecent advancement in white biotechnology through fungi: volume 1: diversity and enzymes perspectives 2019 Mar 9 (pp. 121-179). Cham: Springer International Publishing.
- Kaur J, Singh AP, Singh AP, Kaur R. White-rot fungus: An updated review. International Journal of Pharmaceutics and Drug Analysis. 2021 Sep;9(3):202-17.
- Loukou E, Jensen NF, Rohde L, Andersen B. Damp buildings: associated fungi and how to find them. Journal of Fungi. 2024 Jan 27;10(2):108.
- Eloff JN, Angeh IE, McGaw LJ. Solvent-solvent fractionation can increase the antifungal activity of a Melianthus comosus (Melianthaceae) acetone leaf extract to yield a potentially useful commercial antifungal product. Industrial Crops and Products. 2017 Dec 30;110:103-12.
- Qun T, Zhou T, Hao J, Wang C, Zhang K, Xu J, Wang X, Zhou W. Antibacterial activities of anthraquinones: Structure–activity relationships and action mechanisms. RSC Medicinal Chemistry. 2023;14(8):1446-71.
- Yount NY, Yeaman MR. Peptide antimicrobials: cell wall as a bacterial target. Annals of the New York Academy of sciences. 2013 Jan;1277(1):127-38.
- Mohamed GA, Ibrahim SR, Asfour HZ. Antimicrobial metabolites from the endophytic fungus Aspergillus versicolor. Phytochemistry Letters. 2020 Feb 1;35:152-5.
- Wang H, Xi Y, Zhang S, Wang Y, Xiao J, Cheng Z, Zhang Z. Recent Advances of Secondary Metabolites From Marine‐Derived Aspergillus versicolor: Chemical Diversity and Bioactivities (2015–2024). Chemistry & Biodiversity. 2025 Dec;22(12):e02414.
- Conrado R, Gomes TC, Roque GS, De Souza AO. Overview of bioactive fungal secondary metabolites: cytotoxic and antimicrobial compounds. Antibiotics. 2022 Nov 11;11(11):1604.
- Raimondi F, Singh G, Betts MJ, Apic G, Vukotic R, Andreone P, Stein L, Russell RB. Insights into cancer severity from biomolecular interaction mechanisms. Scientific reports. 2016 Oct 4;6(1):34490.
- Yang LJ, Peng XY, Zhang YH, Liu ZQ, Li X, Gu YC, Shao CL, Han Z, Wang CY. Antimicrobial and antioxidant polyketides from a deep-sea-derived fungus Aspergillus versicolor SH0105. Marine drugs. 2020 Dec 11;18(12):636.
- Zahir I. Aspergillomarasmine, a promising adjuvant to overcome antibiotic resistance. Journal of Biology and Biomedical Research (ISSN: 3009-5522). 2025 Sep 19;2(1):177-81.
- Diggle SP, Whiteley M. Microbe Profile: Pseudomonas aeruginosa: opportunistic pathogen and lab rat. Microbiology. 2020 Jan;166(1):30-3.
- Nimer NA. Nosocomial infection and antibiotic-resistant threat in the Middle East. Infection and drug resistance. 2022 Jan 1:631-9.
- Mele MA, Kang HM, Lee YT, Islam MZ. Grape terpenoids: Flavor importance, genetic regulation, and future potential. Critical Reviews in Food Science and Nutrition. 2021 May 15;61(9):1429-47.
- Buican BC, Luchian CE, Colibaba LC, Niculaua M, Bordean ME, Kallithraka S, Cotea VV. Aroma Compounds from Grape Pomace: Investigation of Key Winemaking Factors for Future Extraction Applications—A Review. Horticulturae. 2025 Mar 10;11(3):302.
- Sharma AK, Dhasmana N, Dubey N, Kumar N, Gangwal A, Gupta M, Singh Y. Bacterial virulence factors: secreted for survival. Indian journal of microbiology. 2017 Mar;57(1):1-0.
- Abdulateef SA, Owaif HA, Hussein MH. Importance of virulence factors in bacterial pathogenicity: a review. International Journal of Medical Science and Clinical Research Studies. 2023 Apr 22;3(4):765-9.
- Chung J, Eisha S, Park S, Morris AJ, Martin I. How three self-secreted biofilm exopolysaccharides of Pseudomonas aeruginosa, Psl, Pel, and alginate, can each be exploited for antibiotic adjuvant effects in cystic fibrosis lung infection. International Journal of Molecular Sciences. 2023 May 13;24(10):8709.
- Heinz A. Elastases and elastokines: elastin degradation and its significance in health and disease. Critical reviews in biochemistry and molecular biology. 2020 May 3;55(3):252-73.
- Kunz Coyne AJ, El Ghali A, Holger D, Rebold N, Rybak MJ. Therapeutic strategies for emerging multidrug-resistant Pseudomonas aeruginosa. Infectious diseases and therapy. 2022 Apr;11(2):661-82.
- Alharbi MS, Moursi SA, Alshammari A, Aboras R, Rakha E, Hossain A, Alshubrumi S, Alnazha K, Khaja AS, Saleem M. Multidrug-resistant Pseudomonas aeruginosa: Pathogenesis, resistance mechanisms, and novel therapeutic strategies. Virulence. 2025 Dec 31;16(1):2580160.
- Gellatly SL, Hancock RE. Pseudomonas aeruginosa: new insights into pathogenesis and host defenses. Pathogens and disease. 2013 Apr 1;67(3):159-73.
- Qin S, Xiao W, Zhou C, Pu Q, Deng X, Lan L, Liang H, Song X, Wu M. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal transduction and targeted therapy. 2022 Jun 25;7(1):199.
- Kuemmerli R. Iron acquisition strategies in pseudomonads: mechanisms, ecology, and evolution. Biometals. 2023 Aug;36(4):777-97.
- Alanzi A, Elhawary EA, Ashour ML, Moussa AY. Aspergillus co-cultures: A recent insight into their secondary metabolites and microbial interactions. Archives of Pharmacal Research. 2023 Apr 1;46(4).
- Reyes VE. Helicobacter pylori and its role in gastric cancer. Microorganisms. 2023 May 17;11(5):1312.
- Paul J. Gastrointestinal tract infections. InDisease causing microbes 2024 Jan 3 (pp. 149-215). Cham: Springer International Publishing.
- Ansari S, Yamaoka Y. Helicobacter pylori virulence factors exploiting gastric colonization and its pathogenicity. Toxins. 2019 Nov 19;11(11):677.
- Baj J, Forma A, Sitarz M, Portincasa P, Garruti G, Krasowska D, Maciejewski R. Helicobacter pylori virulence factors—mechanisms of bacterial pathogenicity in the gastric microenvironment. Cells. 2020 Dec 25;10(1):27.
- Padhi S, Sharma S, Sarkar P, Masi M, Cimmino A, Rai AK. A Comprehensive Review of Plant and Microbial Natural Compounds as Sources of Potential Helicobacter pylori-Inhibiting Agents. BioTech. 2025 Nov 26;14(4):94.
- Miao FP, Li XD, Liu XH, Cichewicz RH, Ji NY. Secondary metabolites from an algicolous Aspergillus versicolor strain. Marine drugs. 2012 Jan;10(1):131-9.
- Breijyeh Z, Jubeh B, Karaman R. Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules. 2020 Mar 16;25(6):1340.
- Cardos IA, Danila C, Yahya G, Seleem NM, Mosbah RA, Shaldam MA, Vicas SI, Metwally K, Cavalu SD. Targeting Helicobacter pylori enzymes using Viscum album L. extract: in silico molecular docking and in vitro study. Frontiers in Cellular and Infection Microbiology. 2025;15:1690969.
- Ying J, Zhou Z, Tang J, Zhang H. Establishing links between biosynthetic gene clusters in fungi and their secondary metabolites: A case study of Aspergillus. Bioresource Technology. 2026 Apr 5:134535.
- Hafidh RR, Abdulamir AS, Vern LS, Bakar FA, Abas F, Jahanshiri F, Sekawi Z. Inhibition of growth of highly resistant bacterial and fungal pathogens by a natural product. The open microbiology journal. 2011 Aug 16;5:96.
- Yuan B. What personalized medicine humans need and way to it——also on the practical significance and Scientific Limitations of Precision Medicine. Pharmacogenomics and Personalized Medicine. 2022 Dec 31:927-42.
- Bastos RW, Akiyama D, Dos Reis TF, Colabardini AC, Luperini RS, de Castro PA, Baldini RL, Fill T, Goldman GH. Secondary metabolites produced during Aspergillus fumigatus and Pseudomonas aeruginosa biofilm formation. MBio. 2022 Aug 30;13(4):e01850-22.
- Cumming E, Peters C. Immune response to infection. Anaesthesia & Intensive Care Medicine. 2024 Jun 1;25(6):439-43.
- da Silva RM. Evaluation of the antimicrobial potential of natural extracts on Helicobacter Pylori (Master's thesis, Universidade de Coimbra (Portugal)).
- Singh K, Kumari A. Mycotoxins and mycotoxicoses. Singapore:: Springer; 2022 May 17.
